Attention to background strain is essential for metabolic research: C57BL/6 and the international knockout mouse consortium

Diabetes

Volumn 65, Issue 1, 2016, Pages 25-33

  Fontaine, Danielle A ^a   Davis, Dawn Belt ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; C57BL 6 MOUSE; C57BL/6N MOUSE; EMBRYO; GENETIC DIFFERENCE; KNOCKOUT MOUSE; METABOLISM; MOUSE; MOUSE EMBRYONIC STEM CELL; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; SYMBIOSIS; ANIMAL; C57BL MOUSE; DIABETES MELLITUS; DISEASE MODEL; GENETICS; GENOTYPE; INBRED MOUSE STRAIN; METHODOLOGY; TRANSGENIC MOUSE;

CRE RECOMBINASE; DNA POLYMERASE; INTEGRASE; RECOMBINASE;

ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DNA NUCLEOTIDYLTRANSFERASES; GENOTYPE; INTEGRASES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; RESEARCH DESIGN;

EID: 84962169062     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0982     Document Type: Article

References (62)

1. C57BL/6 Mice [Internet], 2011. Charles River Laboratories International, Inc. Available from http://www.criver.com/files/pdfs/rms/c57bl6/ rm-rm-d-c57bl6n-mouse.aspx. Accessed 1 May 2015
2. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973;9:287-293
3. Waterston RH, Lindblad-Toh K, Birney E, et al.; Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-562
4. Pettitt SJ, Liang Q, Rairdan XY, et al. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat Methods 2009;6:493-495
5. Mekada K, Abe K, Murakami A, et al. Genetic differences among C57BL/6 substrains. Exp Anim 2009;58:141-149
6. Toye AA, Lippiat JD, Proks P, et al. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 2005;48: 675-686
7. Collins FS, Rossant J, Wurst W; International Mouse Knockout Consortium. A mouse for all reasons. Cell 2007;128:9-13
8. Skarnes WC, Rosen B, West AP, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 2011;474:337-342
9. Collins FS, Finnell RH, Rossant J, Wurst W. A new partner for the international knockout mouse consortium. Cell 2007;129:235
10. Inbred and Genetically Defined Strains of Laboratory Animals: Mouse and Rat. Altman PL, Katz DD, Eds. Bethesda, MD, Federation of American Societies for Experimental Biology, 1979
11. Origins of Inbred Mice. Morse HC III, Ed. New York, Academic Press, 1978
12. Zurita E, Chagoyen M, Cantero M, et al. Genetic polymorphisms among C57BL/6 mouse inbred strains. Transgenic Res 2011;20:481-489
13. C57BL/6 substrain information [Internet], Envigo (previously Harlan Laboratories), Indianapolis, IN. Available from http://www.envigo.com/resources/data-sheets/envigo-68-c57bl6-enhanced-technical-data-sheet-screen.pdf. Accessed 1 May 2015
14. C57BL/6NRj mouse [Internet], 2013. Janvier Laboratories. Available from http://www.janvier-labs.com/rodent-research-models-services/research-models/ per-species/inbred-mice/product/c57bl6nrj.html. Accessed 1 May 2015
15. Kern M, Knigge A, Heiker JT, et al. C57BL/6JRj mice are protected against diet induced obesity (DIO). Biochem Biophys Res Commun 2012;417:717-720
16. Mao HZ, Roussos ET, Péterfy M. Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strains. Bio-chim Biophys Acta 2006;1762:440-446
17. Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem Genet 1972;7:1-13
18. Simon MM, Greenaway S, White JK, et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol 2013;14:R82
19. Lamming DW, Ye L, Sabatini DM, Baur JA. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 2013;123:980-989
20. Banks G, Heise I, Starbuck B, et al. Genetic background influences age-related decline in visual and nonvisual retinal responses, circadian rhythms, and sleep. Neurobiol Aging 2015;36:380-393
21. Kumar V, Kim K, Joseph C, et al. C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science 2013;342: 1508-1512
22. Watkins-Chow DE, Pavan WJ. Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res 2008;18:60-66
23. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988;37:1163-1167
24. Kaku K, Fiedorek FT Jr, Province M, Permutt MA. Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes 1988;37:707-713
25. Nicholson A, Reifsnyder PC, Malcolm RD, et al. Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide trans-hydrogenase (Nnt) gene. Obesity (Silver Spring) 2010;18:1902-1905
26. Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. Deletion of nicotin-amide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 2006;55:2153-2156
27. Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes 1991;40:82-87
28. Lee SK, Opara EC, Surwit RS, Feinglos MN, Akwari OE. Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 1995;11:206-211
29. Anderson AA, Helmering J, Juan T, et al. Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt. PathoGenetics 2009;2:1
30. Wencel HE, Smothers C, Opara EC, Kuhn CM, Feinglos MN, Surwit RS. Impaired second phase insulin response of diabetes-prone C57BL/6J mouse islets. Physiol Behav 1995;57:1215-1220
31. Aston-Mourney K, Wong N, Kebede M, et al. Increased nicotinamide nu-cleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia 2007;50:2476-2485
32. Andrikopoulos S, Massa CM, Aston-Mourney K, et al. Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol 2005;187:45-53
33. Berglund ED, Li CY, Poffenberger G, et al. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 2008;57:1790-1799
34. Fisher-Wellman KH, Lin CT, Ryan TE, et al. Pyruvate dehydrogenase complex and nicotinamide nucleotide transhydrogenase constitute an energy-consuming redox circuit. Biochem J 2015;467:271-280
35. Fergusson G, Éthier M, Guévremont M, et al. Defective insulin secretory response to intravenous glucose in C57Bl/6J compared to C57Bl/6N mice. Mol Metab 2014;3:848-854
36. Wong N, Blair AR, Morahan G, Andrikopoulos S. The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance. Endocrinology 2010;151:96-102
37. Alonso LC, Watanabe Y, Stefanovski D, et al. Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious un-handled mice. Obesity (Silver Spring) 2012;20:1403-1412
38. Walker A, Pfitzner B, Neschen S, et al. Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J 2014;8:2380-2396
39. Harley ITW, Giles DA, Pfluger PT, et al. Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice. Mol Metab 2013;2:171-183
40. Khisti RT, Wolstenholme J, Shelton KL, Miles MF. Characterization of the ethanol-deprivation effect in substrains of C57BL/6 mice. Alcohol 2006;40:119-126
41. Green ML, Singh AV, Zhang Y, Nemeth KA, Sulik KK, Knudsen TB. Re-programming of genetic networks during initiation of the Fetal Alcohol Syndrome. Dev Dyn 2007;236:613-631
42. Diwan BA, Blackman KE. Differential susceptibility of 3 sublines of C57BL/6 mice to the induction of colorectal tumors by 1,2-dimethylhydrazine. Cancer Lett 1980;9:111-115
43. Ulmasov B, Oshima K, Rodriguez MG, Cox RD, Neuschwander-Tetri BA. Differences in the degree of cerulein-induced chronic pancreatitis in C57BL/6 mouse substrains lead to new insights in identification of potential risk factors in the development of chronic pancreatitis. Am J Pathol 2013;183: 692-708
44. Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci 2004;45:4611-4616
45. Matsuo N, Takao K, Nakanishi K, Yamasaki N, Tanda K, Miyakawa T. Behavioral profiles of three C57BL/6 substrains. Front Behav Neurosci 2010;4: 29
46. Gray JE, Starmer J, Lin VS, Dickinson BC, Magnuson T. Mitochondrial hydrogen peroxide and defective cholesterol efflux prevent in vitro fertilization by cryopreserved inbred mouse sperm. Biol Reprod 2013;89:17
47. Ronchi JA, Figueira TR, Ravagnani FG, Oliveira HCF, Vercesi AE, Castilho RF. A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities. Free Radic Biol Med 2013;63:446-456
48. Erecinska M, Bryta J, Michalik M, Meglasson MD, Nelson D. Energy metabolism in islets of Langerhans. Biochim Biophys Acta 1992;1101:273-295
49. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001;414:807-812
50. Wallace DC. Mouse models for mitochondrial disease. Am J Med Genet 2001;106:71-93
51. Hoek JB, Rydström J. Physiological roles of nicotinamide nucleotide transhydrogenase. Biochem J 1988;254:1-10
52. Huang T-T, Naeemuddin M, Elchuri S, et al. Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase. Hum Mol Genet 2006;15:1187-1194
53. Huang Y-C, Hwang T-L, Yang Y-L, et al. Acetogenin and prenylated flavonoids from Helminthostachys zeylanica with inhibitory activity on superoxide generation and elastase release by neutrophils. Planta Med 2010; 76:447-453
54. Hasselmann C, Deladoëy J, Vuissoz JM, et al. Expanding the phenotypic spectrum of nicotinamide nucleotide transhydrogenase (NNT) mutations and using whole exome sequencing to discover potential disease modifiers. Journal of Genomes and Exomes 2013;1:19-30
55. Weinberg-Shukron A, Abu-Libdeh A, Zhadeh F, et al. Combined mineralo-corticoid and glucocorticoid deficiency is caused by a novel founder nicotinamide nucleotide transhydrogenase mutation that alters mitochondrial morphology and increases oxidative stress. J Med Genet 2015;52:636-641
56. Bourdi M, Davies JS, Pohl LR. Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury. Chem Res Toxicol 2011;24:794-796
57. Taft RA, Davisson M, Wiles MV. Know thy mouse. Trends Genet 2006;22: 649-653
58. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001;29: E88-8
59. Collins A, Ke X. Primer1: primer design web service for tetra-primer ARMS-PCR. Open Bioinform J 2012;6:55-58
60. Mekada K, Hirose M, Murakami A, Yoshiki A. Development of SNP markers for C57BL/6N-derived mouse inbred strains. Exp Anim 2015;64:91-100
61. Vanden Berghe T, Hulpiau P, Martens L, et al. Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice. Immunity 2015;43:200-209
62. Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 2014;32:347-355